ETON
Eton Pharmaceuticals Inc
55.60$
-2.6%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | 47.2% | 733.3% | 12.0% | 32.6% | 33.4% | 40.0% | 46.5% | |
| – | – | 52.8% | -633.3% | 88.0% | 67.4% | 66.6% | 60.0% | 53.5% | |
| – | – | 1,204.9% | 36,164.1% | 28.6% | 18.8% | 10.5% | 8.3% | 9.7% | |
| – | – | 787.5% | 32,717.9% | 66.3% | 87.4% | 59.8% | 58.3% | 44.8% | |
| – | – | 1,992.4% | 68,882.1% | 94.8% | 106.2% | 70.3% | 66.7% | 53.4% | |
| – | – | -1,939.6% | -69,515.4% | -6.8% | -38.9% | -3.8% | -6.7% | 0.1% | |
| – | – | 29.3% | 2,279.5% | 4.8% | 4.5% | 3.3% | 5.1% | 6.0% | |
| – | – | -1,910.3% | -71,717.9% | -9.0% | -42.4% | -2.2% | -9.8% | -5.7% | |
| – | – | -29.3% | 2,202.6% | 4.6% | 3.6% | 0.8% | 0.0% | 0.1% | |
| – | – | -1,910.3% | -71,717.9% | -9.0% | -42.4% | -3.0% | -9.8% | -5.8% | |
| – | – | -1,893.0% | -67,846.2% | -6.8% | -34.1% | 0.7% | -1.7% | 5.3% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.